A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease (Q45367066)
Jump to navigation
Jump to search
scientific article published in August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease |
scientific article published in August 2011 |
Statements
1 reference
A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease (English)
1 reference
Timothy F Feltes
1 reference
Henry M Sondheimer
1 reference
Robert M R Tulloh
1 reference
Brian S Harris
1 reference
Kathryn M Jensen
1 reference
Genevieve A Losonsky
1 reference
M Pamela Griffin
1 reference
Motavizumab Cardiac Study Group
1 reference
1 August 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference